Efficacy and safety of PEGylated recombinant human granulocyte stimulating factor in the prevention of neutropenia during concurrent chemoradiotherapy.

Dongling Zou,Qi Zhou,Mingfang Guo

Efficacy and safety of PEGylated recombinant human granulocyte stimulating factor in the prevention of neutropenia during concurrent chemoradiotherapy.

2020

Dongling Zou
Qi Zhou
Mingfang Guo

e18018Background: This randomized controlled prospective study aims to explore the efficacy and safety of using PEG-rhG-CSF to prevent neutropenia during concurrent chemoradiotherapy of paclitaxel ...

Keywords:

Granulocyte
Oncology
concurrent chemoradiotherapy
Recombinant DNA
Pathology
Internal medicine
Neutropenia
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations